In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study

Kristian Wachtell; Eva Gerdts; Vittorio Palmieri; Michael H. Olsen; Markku S. Nieminen; Vasilios Papademetriou; Kurt Boman; Bjorn Dahlof; Gerard P. Aurigemma; Jens E. Rokkedal; Richard B. Devereux

doi:10.1097/HJH.0b013e328339f943

In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study

Kristian Wachtell
, Eva Gerdts
, Vittorio Palmieri
, Michael H. Olsen
, Markku S. Nieminen
, Vasilios Papademetriou
, Kurt Boman
, Bjorn Dahlof
, Gerard P. Aurigemma
, Jens E. Rokkedal
, Richard B. Devereux

Kardiologian yksikkö

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Journal	Journal of Hypertension
Volume	28
Pages (from-to)	1541-1546
Number of pages	6
ISSN	0263-6352
DOIs	https://doi.org/10.1097/HJH.0b013e328339f943
Publication status	Published - 2010
MoE publication type	A1 Journal article-refereed

Fields of Science

left ventricular hypertrophy
mortality
systolic performance
PRESSURE-OVERLOAD HYPERTROPHY
SYSTEMIC HYPERTENSION
ECHOCARDIOGRAPHIC-ASSESSMENT
ANTIHYPERTENSIVE TREATMENT
ARTERIAL-HYPERTENSION
LIFE
PERFORMANCE
MECHANICS
STRESS
REGRESSION
312 Clinical medicine

Access to Document

10.1097/HJH.0b013e328339f943

Cite this

Wachtell, K., Gerdts, E., Palmieri, V., Olsen, M. H., Nieminen, M. S., Papademetriou, V., Boman, K., Dahlof, B., Aurigemma, G. P., Rokkedal, J. E., & Devereux, R. B. (2010). In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study. Journal of Hypertension, 28, 1541-1546. https://doi.org/10.1097/HJH.0b013e328339f943

@article{38260db252ae48d6b219573aa5e24caa,

title = "In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study",

keywords = "left ventricular hypertrophy, mortality, systolic performance, PRESSURE-OVERLOAD HYPERTROPHY, SYSTEMIC HYPERTENSION, ECHOCARDIOGRAPHIC-ASSESSMENT, ANTIHYPERTENSIVE TREATMENT, ARTERIAL-HYPERTENSION, LIFE, PERFORMANCE, MECHANICS, STRESS, REGRESSION, 312 Clinical medicine",

author = "Kristian Wachtell and Eva Gerdts and Vittorio Palmieri and Olsen, \{Michael H.\} and Nieminen, \{Markku S.\} and Vasilios Papademetriou and Kurt Boman and Bjorn Dahlof and Aurigemma, \{Gerard P.\} and Rokkedal, \{Jens E.\} and Devereux, \{Richard B.\}",

year = "2010",

doi = "10.1097/HJH.0b013e328339f943",

language = "English",

volume = "28",

pages = "1541--1546",

journal = "Journal of Hypertension",

issn = "0263-6352",

publisher = "Lippincott Williams and Wilkins",

}

Wachtell, K, Gerdts, E, Palmieri, V, Olsen, MH, Nieminen, MS, Papademetriou, V, Boman, K, Dahlof, B, Aurigemma, GP, Rokkedal, JE & Devereux, RB 2010, 'In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study', Journal of Hypertension, vol. 28, pp. 1541-1546. https://doi.org/10.1097/HJH.0b013e328339f943

In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study. / Wachtell, Kristian; Gerdts, Eva; Palmieri, Vittorio et al.
In: Journal of Hypertension, Vol. 28, 2010, p. 1541-1546.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study

AU - Wachtell, Kristian

AU - Gerdts, Eva

AU - Palmieri, Vittorio

AU - Olsen, Michael H.

AU - Nieminen, Markku S.

AU - Papademetriou, Vasilios

AU - Boman, Kurt

AU - Dahlof, Bjorn

AU - Aurigemma, Gerard P.

AU - Rokkedal, Jens E.

AU - Devereux, Richard B.

PY - 2010

Y1 - 2010

KW - left ventricular hypertrophy

KW - mortality

KW - systolic performance

KW - PRESSURE-OVERLOAD HYPERTROPHY

KW - SYSTEMIC HYPERTENSION

KW - ECHOCARDIOGRAPHIC-ASSESSMENT

KW - ANTIHYPERTENSIVE TREATMENT

KW - ARTERIAL-HYPERTENSION

KW - LIFE

KW - PERFORMANCE

KW - MECHANICS

KW - STRESS

KW - REGRESSION

KW - 312 Clinical medicine

U2 - 10.1097/HJH.0b013e328339f943

DO - 10.1097/HJH.0b013e328339f943

M3 - Article

SN - 0263-6352

VL - 28

SP - 1541

EP - 1546

JO - Journal of Hypertension

JF - Journal of Hypertension

ER -

Wachtell K, Gerdts E, Palmieri V, Olsen MH, Nieminen MS, Papademetriou V et al. In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study. Journal of Hypertension. 2010;28:1541-1546. doi: 10.1097/HJH.0b013e328339f943